Cargando…
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
BACKGROUND: Brachytherapy is the most commonly used conservative treatment for the uveal melanoma. The aim of this study was to evaluate therapeutic results of Ruthenium-106 plaque brachytherapy in the management of localized uveal melanoma cases. METHODS: We reviewed retrospectively the clinical re...
Autores principales: | Belaïd, Asma, Nasr, Chiraz, Jmour, Omar, Cherif, Aziz, Kochbati, Lotfi, Bouguila, Hedi, Besbes, Mounir, Benna, Farouk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454671/ https://www.ncbi.nlm.nih.gov/pubmed/28125874 http://dx.doi.org/10.22034/APJCP.2016.17.12.5281 |
Ejemplares similares
-
(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020) -
Rare Case of a Well-Differentiated Paratesticular Sarcoma of the Spermatic Cord in a 60-Year-Old Patient
por: Benna, Marwen, et al.
Publicado: (2017) -
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017) -
Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017) -
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)